NDCFind

Eltrombopag 70771-1925-03

Package NDC

70771-1925-03

Product NDC: 70771-1925

Manufacturer
Zydus Lifesciences Limited
Dosage Form
Tablet
Route
Oral
Product Type
Human Prescription Drug
Marketing Start
January 14, 2026
Listing Expires
December 31, 2027
Application
ANDA216281
StockMeds — pharmacy-to-pharmacy marketplace

Need to source Eltrombopag? P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

IngredientStrength
Eltrombopag Olamine12.5 mg/1

Drug Class

Breast Cancer Resistance Protein Inhibitors [MoA]Increased Megakaryocyte Maturation [PE]Increased Platelet Production [PE]

Selected Package

70771-1925-03Selected

30 TABLET in 1 BOTTLE (70771-1925-3)